HEALTH & ASSISTANCE · DOCUMENTED HISTORY

History of medical and healthcare robotics

From the first surgical arms to therapeutic microrobots

Robots help guide instruments, repeat exercises, transport equipment or support interaction. This history connects machines to the needs of patients and teams, while distinguishing research, trials, commercialization and regulatory decisions.

A medical robot does not become a doctor: its use is part of human care and human responsibility.

Documentation: October 12, 2026 · Educational selection, not exhaustive · Each date refers to the milestone described.

da Vinci system presented in Cambridge in 2015, and not the da Vinci 5 model
da Vinci system presented in Cambridge in 2015, and not the da Vinci 5 model. Cmglee · Source · CC BY-SA 3.0. Resized image, same license.

1983–1991 · The first assistants

Positioning, guiding and transporting: the first robots address well-defined tasks.

1983–1985

Arthrobot

Brian Day, James McEwen and Geof Auchinleck
Canada

Surgery
Milestone: Prototype and first experimental uses

A voice-controlled assistant helps position a limb during an orthopedic procedure.

How it works and historical significance

Robotics begins here with mechanical assistance to the team, not with an autonomous surgeon. Historical accounts diverge: Auchinleck's testimony places the idea in 1983, the construction in 1984 and a first procedure on March 12, 1985. The date range avoids presenting 1983 as an undisputed clinical date.

1985–1988

PUMA 200

Yik San Kwoh’s team · Unimation arm
United States

Surgery
Milestone: Early work; scientific publication in 1988

An industrial arm is adapted to position a guide for a brain biopsy under CT control.

How it works and historical significance

The precision depends on the alignment between the images, the patient and the robot. The pioneering work is associated with 1985; the original 1988 publication documents the improvement of the positioning. The robot does not perform a complete brain operation on its own.

1988–1991

PROBOT

Brian Davies and team · Imperial College / Guy’s Hospital
United Kingdom

Surgery
Milestone: Research then clinical application in April 1991

PROBOT performs the resection of prostatic tissue inside a volume defined by the surgeon.

How it works and historical significance

The clinical milestone described by Imperial College is April 1991. It must be distinguished from research from the late 1980s. The automation concerns a bounded task, with medical preparation and responsibility; it does not mean general autonomy.

1989

HelpMate

Transitions Research Corporation
United States

Hospital robotics
Milestone: Technical publication

A mobile robot transports objects through hospital corridors.

How it works and historical significance

Navigation combines a representation of the environment and sensors to avoid obstacles. The 1989 publication is the documentary reference retained: on its own, it does not set a universal date of commercialization. Logistics frees up time without performing a medical act.

1991–1994 · Measuring and preparing

Bone planning and rehabilitation open up new applications.

1991–1994

MIT-MANUS

Neville Hogan, Hermano Krebs and colleagues · MIT
United States

Rehabilitation
Milestone: Development followed by preparation of clinical trials

An interactive device accompanies arm movements and measures effort for rehabilitation.

How it works and historical significance

MIT-MANUS is documented as early as 1991. In March 1994, MIT describes trials planned for the autumn. Measurement and assistance make it possible to study reproducible exercises; relevance depends on the patient's situation and the therapeutic program.

1992

ROBODOC

Integrated Surgical Systems · work with IBM
United States

Surgery
Milestone: Human feasibility study in 1992–1993

ROBODOC prepares the femur for the placement of a hip prosthesis, according to a plan derived from imaging.

How it works and historical significance

The Smithsonian archives describe the authorization of a limited human study in Sacramento in 1992–1993. This was a trial milestone, to be distinguished from a general commercial authorization. Bone milling is a specialized task, prepared and supervised.

1994

IRCAD

Jacques Marescaux and his team
France · Strasbourg

Surgery
Milestone: Creation of a research and training center

IRCAD develops an environment for research, training and exchange in minimally invasive surgery.

How it works and historical significance

Its thirtieth anniversary in 2024 places its creation in 1994. The contribution is not limited to a machine: training teams, sharing practices and conducting experimental work accompanies the evolution of techniques.

1999–2005 · Consoles and companions

Remote surgery, guided walking and sensory assistance: several avenues are developing.

1999–2000

da Vinci

Intuitive Surgical
United States

Surgery
Milestone: Sales outside the United States in 1999; FDA decision in 2000

The surgeon controls articulated instruments from a console, with visualization of the operating field.

How it works and historical significance

Intuitive's report places the first sales outside the United States in the second quarter of 1999. The FDA issued a 510(k) decision on July 11, 2000 for specific uses. Indications subsequently evolved: this decision does not amount to authorization for all procedures, nor to French authorization.

2001

Operation Lindbergh

Jacques Marescaux and team · IRCAD · ZEUS system
France / United States

Surgery
Milestone: Clinical demonstration of telesurgery

On September 7, 2001, a team in New York operated on a patient in Strasbourg to remove her gallbladder.

How it works and historical significance

The procedure used ZEUS, not da Vinci. The transmission of commands demonstrated the crucial role of latency, the reliability of communications, and the team present with the patient. This historic success does not mean that transatlantic telesurgery became a routine practice.

2001

Lokomat

Hocoma · collaboration with Balgrist
Switzerland

RehabilitationProsthetics and exoskeletons
Milestone: Commercialization

A motorized orthosis guides the legs on a treadmill with body-weight support.

How it works and historical significance

The manufacturer places the market launch in 2001. The device makes it possible to organize repetitive walking exercises, with therapeutic adjustments and monitoring. Guided training does not guarantee identical recovery for every patient.

2004–2005

PARO

Takanori Shibata · AIST
Japan

Assistance and companionship
Milestone: Announcement in 2004; commercialization in 2005

This baby seal-shaped robot reacts to touch and other sensory stimuli.

How it works and historical significance

The 2004 announcement precedes the Japanese sales documented from 2005 onward. PARO can serve as a support for accompanied interaction. It is not a living animal and does not replace human relationships or care; its acceptability depends on the person and the context.

2007–2014 · From trajectories to mobility

Neurosurgery, exoskeletons and motorized prostheses cross regulatory milestones.

2007–2009

ROSA Brain

Medtech · Bertin Nahum
France · Montpellier

Surgery
Milestone: Development in 2007; CE marking in 2008; FDA in 2009

ROSA supports neurosurgical procedures by linking planning and the positioning of a robotic arm.

How it works and historical significance

Medtech's base document distinguishes the stages of development and certification. The guidance helps the team reach planned trajectories. ROSA Brain should not be confused with the ROSA systems later intended for other specialties, including the knee.

2014

ReWalk

Argo Medical Technologies / ReWalk Robotics
Israel / United States

Prosthetics and exoskeletons
Milestone: FDA De Novo decision, June 26, 2014

A motorized exoskeleton assists certain users with a spinal cord injury in standing and walking.

How it works and historical significance

2014 is here an American regulatory step, not the date of invention. User selection, training and conditions of use remain decisive. Mechanical assistance does not repair the spinal cord and is not automatically suitable for all paralyzed people.

2014

DEKA Arm

DEKA Research and Development
United States

Prosthetics and exoskeletons
Milestone: American regulatory decision in May 2014

A motorized upper-limb prosthesis coordinates several joints to perform functional tasks.

How it works and historical significance

Control systems use signals from the user. The evaluation focuses on the tasks actually accomplished, not just the number of motors. A prosthesis replaces a missing function; an exoskeleton assists an existing limb: their goals and constraints differ.

2019–2022 · Interfaces and small scales

Brain signals and cell manipulation broaden the research.

2019

Clinatec · brain–exoskeleton interface

CEA · CHU Grenoble Alpes · team of Alim-Louis Benabid
France

Prosthetics and exoskeletonsRehabilitation
Milestone: Published proof of concept

A tetraplegic participant controls the movements of an exoskeleton using brain signals recorded by implants.

How it works and historical significance

The demonstration published in The Lancet Neurology is an experimental proof of concept. The device was used in a controlled environment with safety support: it does not demonstrate autonomous free walking at home, nor a commercially available solution for everyone.

2022

Microrobots for manipulating cells

ISIR · CNRS / Sorbonne Université
France

Medical microrobotics
Milestone: Laboratory research

Microscopic objects driven by optical tweezers make it possible to manipulate cells.

How it works and historical significance

This research combines manipulation, perception and force feedback. The original article is from September 2022; a republication in 2025 does not constitute a new invention. Cell manipulation in a laboratory is not a treatment performed inside the human body.

2024–2026 · Force feedback and microrobots

Commercialized systems are progressing while others remain experimental.

2024

da Vinci 5

Intuitive Surgical
United States

Surgery
Milestone: FDA decision announcement, March 14, 2024

The fifth generation notably brings force feedback and developments to the control platform.

How it works and historical significance

The manufacturer's announcement describes an American regulatory decision and a gradual initial rollout. The assistance and computing functions do not make the system an autonomous surgeon. A technical improvement must be distinguished from a clinical benefit established for each indication.

2025

Microrobots guided by learning

Daniel Ahmed and team · ETH Zurich
Switzerland

Medical microrobotics
Milestone: Peer-reviewed experimental study

Microrobots trained through learning are steered by ultrasound through channels that replicate vascular networks.

How it works and historical significance

The June 2025 study combines simulation and microfluidic experiments. Laboratory channels are not the vessels of a treated patient. The work explores navigation; it does not demonstrate an authorized autonomous human therapy.

2025–2026

Therapeutic magnetic capsules

Bradley Nelson, Salvador Pané and teams · ETH Zurich
Switzerland

Medical microrobotics
Milestone: Preclinical experiments; presentation in 2026

Capsules containing magnetic particles are guided and studied to deliver substances locally.

How it works and historical significance

The November 2025 announcement describes vascular models and trials in large animals. The January 2026 presentation outlines research perspectives. Despite their potential, this work is not proof of routine clinical use in humans; safety, elimination and evaluation remain essential.

Six families, six healthcare needs

Surgery

From trajectory guides to consoles, the robot transmits, stabilizes or executes a planned task. PUMA, ROBODOC, PROBOT, da Vinci and ROSA illustrate different modes of control. The team chooses the indications, verifies the system and manages complications.

Rehabilitation

MIT-MANUS and Lokomat make it possible to measure and repeat movements with adjustable assistance. Repetition alone is not a guarantee of effectiveness: exercises, the patient’s effort and the therapist’s follow-up remain essential. The home adds safety and supervision constraints.

Prosthetics and exoskeletons

The DEKA Arm replaces functions of the upper limb; ReWalk assists the mobility of an equipped user. Fitting, training, energy, cost and selection determine use. A cerebral proof of concept like Clinatec remains distinct from a product for daily life.

Hospital robotics

HelpMate demonstrates the value of autonomous logistics: transporting supplies and moving through corridors. The robot must coexist with patients and professionals. Reliability, access to areas and the organization of flows determine the real gain.

Assistance and companionship

PARO serves as a sensory and relational mediator. The person must be able to accept or refuse the interaction. Robots do not replace a human presence and must not raise undemonstrated therapeutic expectations.

Medical microrobotics

Manipulating cells, navigating channels or guiding capsules opens up promising research. In vitro and animal results are not available human care. Biocompatibility, control, localization and elimination must be evaluated.

France: research, training and precision

In Strasbourg, IRCAD has connected research and training since 1994; the 2001 Operation Lindbergh illustrates a major contribution to telesurgery. In Montpellier, Medtech developed ROSA Brain starting in 2007, before the CE and FDA milestones.

In Grenoble, Clinatec brings together hospital teams and the CEA around brain–machine interfaces. In Paris, research at ISIR, CNRS and Sorbonne Université explores cell manipulation. These examples cover different levels of maturity and do not form a ranking of institutions.

Outlook: moving forward without confusing promise with care

AI and human control

AI can contribute to perception, image analysis or planning. Autonomy in navigation or positioning does not mean autonomy in medical decision-making. The force feedback of da Vinci 5 and the learning of microrobots serve different functions.

Hospital, home and support

Logistical assistance and home exercises can broaden uses. Their value must be established in the real context: supervision, maintenance, accessibility, acceptability and the protection of people matter as much as the technical demonstration.

Safety, data and regulation

Medical devices intended for the European market fall under an evaluation and surveillance framework, notably Regulation 2017/745. An FDA decision concerns the United States and specific uses; it is not equivalent to a universal authorization.

Cybersecurity must be monitored throughout the life cycle: access, updates, communications and continuity of use. Patient data, consent and responsibility must be examined with the relevant teams. An industry announcement alone does not prove a superior clinical benefit.

Sources and references

Priority to original publications, public bodies, laboratories and contemporary documents. Manufacturers document their own announcements and histories; their statements do not constitute an independent clinical evaluation. For Arthrobot, the accounts diverge: the date range and the nature of the testimony are made explicit.

The introductory photograph is authentic, credited and reusable under CC BY-SA; it shows a system in 2015, not the model 5. The illustrated historical documents remain accessible via the cards’ links where their reuse is not established. No generated image is presented as an archive.

NewsRobotique · FJVR · Editorial method · About · Legal notice · Contact

FREN